Responses
Poster
IGCS20_1391
365 Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy for advanced ovarian, fallopian tube and primary peritoneal cancer patients
Compose a Response to This Article
Other responses
No responses have been published for this article.